[1]
Wijdan Abdullameer Kamel, “Biochemical and Clinical Evaluation of Novel Tyrosine Kinase Inhibitors in Breast Cancer: Molecular Docking and Biomarker Correlation Study”, IJSRIS, vol. 5, no. 2, pp. 252–265, Apr. 2026.